These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16925248)

  • 21. The impact of bariatric surgery on nonalcoholic steatohepatitis.
    Rabl C; Campos GM
    Semin Liver Dis; 2012 Feb; 32(1):80-91. PubMed ID: 22418890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bariatric surgery for morbid obesity--a cure for metabolic syndrome?
    Kini S; Herron DM; Yanagisawa RT
    Med Clin North Am; 2007 Nov; 91(6):1255-71, xi. PubMed ID: 17964919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity surgery: evidence for diabetes prevention/management.
    Cummings S; Apovian CM; Khaodhiar L
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S40-4. PubMed ID: 18358255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of all Types of Metabolic Bariatric Surgery and its Consequences: a Systematic Review and Meta-Analysis.
    Khosravi-Largani M; Nojomi M; Aghili R; Otaghvar HA; Tanha K; Seyedi SHS; Mottaghi A
    Obes Surg; 2019 Feb; 29(2):651-690. PubMed ID: 30443720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time for diabetes surgery is it coming?
    Bringer J
    Diabetes Metab; 2009 Dec; 35(6 Pt 2):497. PubMed ID: 20152733
    [No Abstract]   [Full Text] [Related]  

  • 27. Daylong pituitary hormones in morbid obesity: effects of bariatric surgery.
    Camastra S; Manco M; Frascerra S; Iaconelli A; Mingrone G; Ferrannini E
    Int J Obes (Lond); 2009 Jan; 33(1):166-72. PubMed ID: 19050673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial changes in gut regulatory peptides in gastric bypass patients.
    Holdstock C; Zethelius B; Sundbom M; Karlsson FA; Edén Engström B
    Int J Obes (Lond); 2008 Nov; 32(11):1640-6. PubMed ID: 18794895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiology of weight loss surgery.
    Park CW; Torquati A
    Surg Clin North Am; 2011 Dec; 91(6):1149-61, vii. PubMed ID: 22054145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma ghrelin and gastric pacing in morbidly obese patients.
    Cigaina V; Hirschberg AL
    Metabolism; 2007 Aug; 56(8):1017-21. PubMed ID: 17618944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathophysiology of severe obesity and the effects of surgically induced weight loss.
    Sugerman HJ
    Surg Obes Relat Dis; 2005; 1(2):109-19. PubMed ID: 16925225
    [No Abstract]   [Full Text] [Related]  

  • 32. Incretins, diabetes, and bariatric surgery: a review.
    Fetner R; McGinty J; Russell C; Pi-Sunyer FX; Laferrère B
    Surg Obes Relat Dis; 2005; 1(6):589-97; discussion 597-8. PubMed ID: 16925299
    [No Abstract]   [Full Text] [Related]  

  • 33. Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women.
    Sodowski K; Zwirska-Korczala K; Kuka D; Kukla M; Budziszewska P; Czuba B; Włoch A; Cnota W; Bielański W; Brzozowski T; Rehfeld JF; Zdun R; Konturek PC
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():37-52. PubMed ID: 17443026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men.
    Brennan IM; Otto B; Feltrin KL; Meyer JH; Horowitz M; Feinle-Bisset C
    Peptides; 2007 Mar; 28(3):607-11. PubMed ID: 17129639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of bariatric surgery to Müllerian-inhibiting substance levels.
    Merhi ZO; Minkoff H; Feldman J; Macura J; Rodriguez C; Seifer DB
    Fertil Steril; 2008 Jul; 90(1):221-4. PubMed ID: 17727846
    [No Abstract]   [Full Text] [Related]  

  • 36. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and considerations in the bariatric surgery patient.
    Takahashi AM
    Clin Podiatr Med Surg; 2007 Apr; 24(2):191-222. PubMed ID: 17430767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of surgically induced weight loss on pelvic floor disorders in morbidly obese women.
    Wasserberg N; Petrone P; Haney M; Crookes PF; Kaufman HS
    Ann Surg; 2009 Jan; 249(1):72-6. PubMed ID: 19106678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients.
    Zalesin KC; McCullough PA
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):403-17. PubMed ID: 17045226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yes, Virginia, bariatric surgery works, and it is safe.
    Pories WJ
    N C Med J; 2006; 67(4):296-300. PubMed ID: 17066661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.